Advertisement

Rare Kidney Tumors

Comprehensive Multidisciplinary Management and Emerging Therapies

  • Gabriel G. Malouf
  • Nizar M. Tannir

Table of contents

  1. Front Matter
    Pages i-ix
  2. Eric Jonasch, Patrick G. Pilie
    Pages 1-10
  3. Marie V. Nelson, Arnauld Verschuur, Jeffrey S. Dome
    Pages 11-29
  4. Ryan D. Bitar, Najat C. Daw
    Pages 31-41
  5. Aaron R. Lim, W. Kimryn Rathmell
    Pages 43-51
  6. Ramaprasad Srinivasan, Kai Hammerich
    Pages 53-63
  7. Pavlos Msaouel, Priya Rao, Nizar M. Tannir
    Pages 65-75
  8. Hendrik Van Poppel, Evelyne Lerut, Raymond Oyen, Maria Debiec-Rychter, Herlinde Dumez, Maarten Albersen et al.
    Pages 77-92
  9. James I. Geller, Nicholas G. Cost, Mariana M. Cajaiba
    Pages 93-104
  10. Borchiellini Delphine, Ambrosetti Damien, Barthélémy Philippe
    Pages 105-128

About this book

Introduction

This book provides clinicians with clear guidance on treatment decision-making in patients with rare kidney cancers. After a brief review on epidemiology, pathology, and biology, each chapter focuses on the multidisciplinary management of a particular tumor subtype using the full range of available cancer therapy modalities, including surgery, radiotherapy, chemotherapy, targeted therapies, and immunotherapy. Emerging therapies and future directions in the management of each cancer subtype are also discussed. The chapters are all written by multidisciplinary teams of international experts comprising at least a urologist, a medical oncologist, and a pathologist.

Rare kidney cancers represent 15% of renal cell carcinomas. In comparison with clear cell renal cell carcinomas, little is known about the biology of such cancers, and few trials have reported on the efficacy of targeted therapies in the metastatic setting. Optimal management thus poses significant challenges and often requires a multidisciplinary team. This book will be an ideal reference guide for all clinicians involved in the care of patients with these orphan tumors.

 

Keywords

Rare Kidney Cancer Management Surgery Chemortherapy Orphan Renal Cell Carcinoma Targeted Therapy

Editors and affiliations

  • Gabriel G. Malouf
    • 1
  • Nizar M. Tannir
    • 2
  1. 1.Department of Hematology and OncologyStrasbourg University Hospital, Hopital CivilStrasbourgFrance
  2. 2.Department of Genitourinary Medical OncologyMD Anderson Cancer CenterHoustonUSA

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-319-96989-3
  • Copyright Information Springer Nature Switzerland AG 2019
  • Publisher Name Springer, Cham
  • eBook Packages Medicine
  • Print ISBN 978-3-319-96988-6
  • Online ISBN 978-3-319-96989-3
  • Buy this book on publisher's site
Industry Sectors
Pharma
Health & Hospitals
Biotechnology
Oncology & Hematology